Background: Obesity is an increasingly metabolic disorder worldwide. Therefore, obesity comorbidities and risk factors are increasing.
Both body mass index (BMI) and body fat percentage (BF%) have been used to define whole-body obesity 6 . Body mass index (BMI) is commonly used for the prediction of health risks 6 . According to the criteria of World Health Organization (WHO), subject with BMI of 30 or 25 kg/m 2 is considered obese or overweight 6 . Body fat percentage is the amount of body fat mass expressed as a percentage of total body weight 6 . The range of BMI is as follows: underweight below 18.5 BMI, normal 18.5-24.9 BMI, overweight 25.0-29.9 BMI and obese 30 and above BMI.
According to WHO, the prevalence of overweight and obesity in Saudi Arabia is 69%, and 33% respectively; in males 69.1%, 28.6% in and females 68.8%, 39.1% 7 .
The prevalence of diabetes and hypertension in Saudi Arabia are very high compared to other countries 1 . Screening for high BF% and/or high BMI is essential to detect and prevent cardiometabolic diseases. BMI cut-off for overweight as defined by the WHO for Asians may not be adequate to reflect the actual overweight. Studies in other countries showed that the risk for cardiovascular disease or diabetes is high at lower BMI 6 . Therefore, a personalized cut-off point for the population of Saudi Arabia is called for.
The aim of this study is to evaluate BMI and BF% in relation to hypertension, type 2 diabetes mellitus (DM-II), and dyslipidemia.
METHOD
A study in both genders aged 18 years and above was conducted from 24 to 26 February 2013. A total of 711 subjects, 355 (49.9%) males and 356 (50.1%) females responded and agreed to participate. Newly discovered diabetes and hypertension cases were referred to primary health care center for further evaluation and follow-up. Data were collected by a personal face-to-face inquiry.
Body height and weight measurements (using a Stadiometer and digital weight scale) were recorded for each participant. BMI was calculated as body weight (kilograms) divided by height (meters square) 8 . WHO classification of BMI and the American Council of Exercise (ACE) classification for BF (>25 for males and >32 for females) were adopted.
Brachial blood pressures were measured in the left arm. Three readings were taken; the mean was used for analysis. Peripheral pulse pressure was calculated as the difference between brachial systolic and diastolic BP 9 . Capillary blood capillary glucose test was performed 10 .
Two consecutive MF-BIA measurements were taken within 20 minutes of the blood sampling with the subject in supine position, before serum osmolality results were available (the assessor was blinded to hydration status). MF-BIA measurements were taken using the manufacturers recommended method 11 .
Adults 18 years and above were included in the study. Exclusion criteria included visitors below 18 years or having type-I DM, hypothyroidism, thyrotoxicosis, tuberculosis, end stage liver or renal failure or known cancer. Informed consent was obtained.
Data were analyzed using JMP version 5.0 and SPSS version 15.0, P<0.05 was considered significant.
RESULT
The study consisted of 711 participants, the mean age was 18 to 60 years (40±12.9 years), 355 (50.6%) were males. The overall prevalence of obesity using BMI (>30 kg/m2) was 334 (47%) (Mean 30.6, CI: 30.08-31.23), compared to 466 (65.5%) (Mean 33.9, CI: 32.4-35.4) using BF% (>32% in females and >25% in males), see tables 1, 2 and 3. When the BMI cut-off point was lowered to 27.5, the overall prevalence of obesity became 459 (64.6%) and the gender-specific prevalence of obesity went up to 216 (60.8%) for males and 244 (68.7%) for females, which is closer to that of BF% results. McNemar test revealed no statistically significant difference between the two prevalence values at that point (P-value 0.143 for males and 0.608 for females).
Sensitivity, specificity and likelihood ratio (LR) of BMI according to BF% cut-offs points (25 in males and 32 in females) were calculated by ROC curve analysis. This revealed that BMI of 27.5 had much higher sensitivity than BMI of 30 in females (P-value 0.001). However, in males there was a decrease in specificity by 26% and increased in sensitivity by 4% P=0.001, see table 4. In addition, sensitivity, specificity and LR of BF% cut-off points were also calculated by ROC curve analysis using BMI at 30 and BMI at 27.5 which revealed that lowering the BMI cut-off point from 30 to 27.5 doubled the likelihood ratio (2.7 to 6.1 for females, 2.6 to 6.3 for males), and increased the specificity (64% to 85% for females and 63% to 86% for males) with a minor decrease in sensitivity (97% to 93% for females and 98% to 93% for males).
Due to the small sample size, both male and female BMI groups (underweight <18.5, normal <25, obese class II 35-40 and obese class III >40) were merged in one group.
Overweight and obese individuals showed a higher percentage of diabetes, hypertension and dyslipidemia. This was found to be significant in female patients (P≤0.05). However, only male patients showed significant results with hypertension (P=0.0457).
The sensitivity and specificity of BF, BMI 30 and BMI 27.5 in detecting the risk of DM-II, hypertension and dyslipidemia are listed in table 4. The sensitivity of BMI 27.5 was higher than that of BMI 30 for diabetes, hypertension and dyslipidemia. However, the specificity was lower for BMI-27.5 compared to BMI-30. Therefore, a lowered cut-off point of BMI gives us a better screening tool for the previously mentioned co-morbidities. The sensitivity of BMI 27.5 and BF% was higher in females and the specificity was higher in males.
DISCUSSION
Obesity has been proposed as the most important determinant for metabolic syndrome. Therefore, it is important to develop simple and reliable anthropometric measurement tools for obesity, to facilitate the prevention of metabolic syndrome and consequent morbidity and mortality 12 .
BMI is directly related to health risks and death rates in many populations. It should be kept in mind that BMI is associated with fat free mass and to a lesser extent to body build 13 . In addition, the associations between BMI, percentage of body fat, and body fat distribution differ across populations. Hence, a population specific BMI cut-off point is called for.
The associations of BMI and comorbidities are probably not stable within populations over time. Similarly, there are environmentally determined differences in these associations across different population groups and these associations also vary within populations according to environmental changes and nutritional transitions.
Our study showed that the prevalence of obesity according to BMI (>30 kg/m2) was 47% (mean 30.6, CI 30.08-31.23), compared to 66.5% (mean 33.9, CI 32.4-35.4) according to BF%. A McNemar test was done to compare the significance between BMI-30 and BF% which revealed significant values. After lowering BMI to 27.5, the prevalence increased up to 64.5%, which is closer to the BF% prevalence. In addition, McNemer test was done to compare the prevalence between BMI 27.5 and BF%, which indicated no significant value for both males and females. Habib found that the lower cut-off points for males and females were 26.6 and 26.75 respectively 14 .
Previous studies showed that the risk of cardiovascular disease or diabetes is high at a lower BMI level 6 . The prevalence of hypertension, diabetes, dyslipidemia, and risk factors increases with an increasing BMIs 15 . Therefore, we developed crosstabs sensitivity and specificity models for hypertension, DM-II, dyslipidemia and average BF% based on the use of international BMI cut-off point 30 and the suggested BMI 27.5. Data suggests that a BMI of 27.5 kg 2 in either sex may be more 'appropriate' to be considered as a cut-off point in Saudi nationals. For females, the BF% and 27.5 BMI showed significantly higher sensitivity values than BMI 30 in predicating DM, hypertension and dyslipidemia, although significant values were only seen with hypertension in males.
CONCLUSION
The sensitivity of BMI 27.5 was higher than that of BMI 30 which gives us a better screening tool for the co-morbidities. The choice of BF% reference is of great influence for the assessment of obesity prevalence compared to the BMI.
